GLP-1 weight-loss medications are associated with significant changes in social and economic outcomes for women, including a 29% increase in marriage and cohabitation rates and a 27% rise in employment prospects, according to preliminary research from Harvard University. The findings suggest these outcomes are tied to successful weight loss achieved through the drugs.
The study, which analyzed data from the Understanding America Study, compared women who began using GLP-1s for weight loss with those who intended to but had not yet started. Researchers focused on women, as they are more likely to use these medications for weight management, and excluded individuals using GLP-1s for diabetes. The analysis controlled for body mass, health, income, employment, partnership status, and well-being prior to treatment.
For single women, the period of observation, approximately 18 months, saw a notable increase in marriage and cohabitation. Among women who were not employed at the study's outset, job prospects improved significantly. However, individuals already employed did not demonstrate clear career advancements.
Researchers theorize that these improvements may reflect societal biases, particularly in situations of new social or professional connections. Dr. Peter Balazs, a hormone and weight-loss specialist not involved in the study, commented that the effects were observed primarily in "new match" scenarios like job interviews or initial dating phases, rather than within established relationships or jobs. He suggested that increased confidence and visibility following weight loss could contribute to better performance in interviews and networking. Balazs also noted potential hormonal impacts and the psychological relief associated with weight loss could play a role.
Dr. Krishna Vyas, a plastic surgeon also not involved in the research, corroborated the confidence boost patients experience after significant weight loss, which can lead them to "re-engage with life." He pointed out, however, that the study did not find a corresponding clear improvement in depression, loneliness, or life satisfaction, suggesting the external changes might be more influential than internal shifts in well-being.
Potential limitations of the study include its observational nature, which precludes establishing a direct cause-and-effect relationship. The findings are also considered preliminary as the paper has not undergone peer review. Further, the focus solely on women may introduce bias, and the reliance on self-reported data means researchers could not verify income increases or other specific metrics. The study's author acknowledged that while GLP-1 users showed better outcomes on paper, they did not report greater overall life satisfaction, raising questions about the translation of these external changes into meaningful well-being improvements.